Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
Noor, Zorawar S., Goldman, Jonathan W., Lawler, William E., Telivala, Bijoy, Braiteh, Fadi, DiCarlo, Brian A., Kennedy, Kathleen, Adams, Brad, Wang, Xiaoyan, Jones, Benjamin, Slamon, Dennis J., Garon, Edward B.
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2019)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2019)
Get full text
Journal Article
Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival
Yardley, Denise A, Kaufman, Peter A, Huang, Weidong, Krekow, Lea, Savin, Michael, Lawler, William E, Zrada, Stephen, Starr, Alexander, Einhorn, Harvey, Schwartzberg, Lee S, Adams, John W, Lie, Yolanda, Paquet, Agnes C, Sperinde, Jeff, Haddad, Mojgan, Anderson, Steve, Brigino, Marlon, Pesano, Rick, Bates, Michael P, Weidler, Jodi, Bosserman, Linda
Published in Breast cancer research : BCR (18.03.2015)
Published in Breast cancer research : BCR (18.03.2015)
Get full text
Journal Article
Primary analysis from the phase 2 study of continuous talazoparib (TALA) plus intermittent low-dose temozolomide (TMZ) in patients with relapsed or refractory extensive-stage small cell lung cancer (ES-SCLC)
Goldman, Jonathan W., Cummings, Amy Lauren, Mendenhall, Melody A., Velez, Maria A, Babu, Sunil, Johnson, Tirrell T., Alcantar, Juan M., Dakhil, Shaker R., Kanamori, David E., Lawler, William E., Anand, Sidharth, Chauv, James, Garon, Edward B., Slamon, Dennis J.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
KRYSTAL-12: A randomized phase 3 study of adagrasib (MRTX849) versus docetaxel in patients (pts) with previously treated non-small-cell lung cancer (NSCLC) with KRAS G12C mutation
Mok, Tony S. K., Lawler, William E., Shum, Merrill Kingman, Dakhil, Shaker R., Spira, Alexander I., Barlesi, Fabrice, Reck, Martin, Garassino, Marina Chiara, Spigel, David R., Alvarez, Delia, Kheoh, Thian, Paxton, William, Chao, Richard C., Felip, Enriqueta
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer
Hurvitz, Sara A., Wang, Lisa S., Chan, David, Phan, Vu, Lomis, Thomas, McAndrew, Nicholas Patrick, Spring, Laura, Tetef, Merry L., Villa, Deborah, Applebaum, Steven, Chamberlain, Erin, Dakhil, Shaker R., DiCarlo, Brian Anthony, Kim, David D., Kirimis, Evangelia K., Lawler, William E., Master, Aashini K., Kivork, Christine, Chauv, James, Bardia, Aditya
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Circulating tumor DNA (ctDNA) mutations may predict treatment response in extensive-stage small cell lung cancer (ES-SCLC) treated with talazoparib and temozolomide (TMZ)
Mulroy, Matthew C, Cummings, Amy Lauren, Mendenhall, Melody A., Kanamori, David E., Nguyen, Andrew V., Kim, David Dae-Young, Lawler, William E., Johnson, Tirrell T., Tseng, Jennifer, Babu, Sunil, Brown, Andrew Bennett, Dakhil, Shaker R., Anand, Sidharth, Wainberg, Zev A., Slamon, Dennis J., Garon, Edward B., Goldman, Jonathan Wade
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Abstract GS2-03: GS2-03 TRIO-US B-12 TALENT: Neoadjuvant trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer
Bardia, Aditya, Hurvitz, Sara, Press, Michael F., Wang, Lisa S., McAndrew, Nicholas P., Chan, David, Phan, Vu, Villa, Deborah, Tetef, Merry L., Chamberlain, Erin, Abdulla, Nihal, Lomis, Thomas, Spring, Laura M., Applebaum, Steven, Dakhil, Shaker, DiCarlo, Brian, Kim, David D., Kirimis, Evangelia, Lawler, William E., Master, Aashini K., McCann, Kelly, Hayashi, Edwin, Kivork, Christine, Chauv, James
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib in combination with rituximab for previously treated indolent non-Hodgkin lymphomas (iNHL)
Salles, Gilles A., Ervin, Thomas J., Dichmann, Robert, Ramchandren, Rod, Page, Ray D., Battini, Ramakrishna, Lawler, William E., Holes, Leanne, Adewoye, Adeboye H., De Vos, Sven
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Corporate criminal liability in the US
Tuohey, Mark H, Lawler, William E, Margolis, Craig D
Published in International commercial litigation (01.12.1996)
Get full text
Published in International commercial litigation (01.12.1996)
Journal Article